Antix Holdings, Inc. (IMTH) — SEC Filings

Antix Holdings, Inc. (IMTH) — 17 SEC filings. Latest: 8-K (Oct 6, 2025). Includes 9 8-K, 5 10-Q, 1 8-K/A.

View Antix Holdings, Inc. on SEC EDGAR

Overview

Antix Holdings, Inc. (IMTH) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Oct 6, 2025: AnTix Holdings, Inc. filed an 8-K on October 6, 2025, reporting a material definitive agreement and the completion of an acquisition or disposition of assets as of October 3, 2025. The filing also included Regulation FD disclosures and financial statements. AnTix Holdings, Inc. was formerly known as

Sentiment Summary

Across 17 filings, the sentiment breakdown is: 17 neutral. The dominant filing sentiment for Antix Holdings, Inc. is neutral.

Filing Type Overview

Antix Holdings, Inc. (IMTH) has filed 9 8-K, 5 10-Q, 1 8-K/A, 1 10-Q/A, 1 10-K with the SEC between Jan 2024 to Oct 2025.

Filings by Year

2025 · 2024

Recent SEC Filings (17)

Antix Holdings, Inc. SEC Filing History
DateFormDescriptionRisk
Oct 6, 20258-KAnTix Holdings Completes Asset Acquisition/Dispositionmedium
Sep 29, 20258-KAnTix Holdings Changes Fiscal Year Endlow
Aug 8, 20258-KInnovative MedTech Files 8-K: Agreements, Obligations, Equity Salesmedium
Jun 9, 20258-KInnovative MedTech Files 8-K on New Agreements & Equity Salesmedium
Jun 2, 20258-KInnovative MedTech Files 8-K: Material Agreement & Equity Salesmedium
May 20, 202510-QInnovative MedTech Files 10-Q for Q3 2025low
May 1, 20258-KInnovative MedTech Files 8-K on Agreements & Acquisitionsmedium
Feb 19, 202510-QInnovative Medtech Files 10-Q, Reports $500M Authorized Sharesmedium
Jan 8, 20258-K/AInnovative MedTech Files 8-K/A Amendmentlow
Nov 20, 202410-Q/AInnovative Medtech Files 10-Q/A Amendmentmedium
Nov 19, 202410-QInnovative Medtech Files Q3 2024 10-Qlow
Oct 16, 202410-KInnovative Medtech Files 2024 10-Klow
Jul 1, 20248-KInnovative MedTech Changes Auditorslow
May 20, 202410-QInnovative Medtech 10-Q: $500M Assets, $22.7M Liabilitiesmedium
Apr 22, 20248-KInnovative MedTech Announces Board and Executive Changesmedium
Feb 16, 202410-QInnovative Medtech, Inc. Files 10-Q for Period Ending December 31, 2023low
Jan 5, 20248-KInnovative MedTech Enters Material Definitive Agreement

Risk Profile

Risk Assessment: Of IMTH's 16 recent filings, 0 were flagged as high-risk, 9 as medium-risk, and 7 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.

Financial Highlights

Antix Holdings, Inc. Financial Summary (10-Q, Feb 16, 2024)
MetricValue
Revenue500000000
Net Income367500
EPS0.000001
Debt-to-Equity0.85
Cash Position500000000
Operating Margin0.95
Total Assets500000000
Total Debt77803

Key Executives

  • Michael Friedman

Industry Context

Innovative Medtech operates in the wholesale of professional and commercial equipment and supplies sector.

Top Tags

material-agreement (5) · 10-Q (5) · financials (5) · equity-sale (4) · corporate-action (3) · acquisition (2) · financial-obligation (2) · quarterly-report (2) · amendment (2) · definitive-agreement (1)

Key Numbers

Antix Holdings, Inc. Key Metrics
MetricValueContext
Total Assets500000000Estimated total assets for the fiscal year ending June 30, 2025.
Net Income367500Net income for the period ending March 31, 2025.
Total Liabilities130000000Estimated total liabilities for the fiscal year ending June 30, 2025.
Revenue23882297Revenue for the period ending March 31, 2025.
Authorized Shares$500.0MIndicates potential for significant equity financing.
Authorized Debt$130.0MShows capacity for debt financing.
Promissory Note Agreement2025-02-01A key subsequent event indicating recent financing activity.
Debt$1.5MRepresents the total amount of outstanding debt as of the reporting period.
Fiscal Period End2024-09-30The end date of the reporting quarter for this 10-Q filing.
Filing Date2024-11-20The date the amended 10-Q/A was officially filed with the SEC.
Total Assets (estimated)500000000Indicates the scale of the company's resources.
Revenue (estimated for prior year)23882297Shows the company's sales performance in the previous fiscal year.
Net Income (estimated for prior year)21157327Reflects the company's profitability in the previous fiscal year.
Fiscal Quarter EndQ3 2024Indicates the period covered by the filing
Reporting Period End Date2023-12-3110-Q filing period

Related Companies

ANTX

Frequently Asked Questions

What are the latest SEC filings for Antix Holdings, Inc. (IMTH)?

Antix Holdings, Inc. has 17 recent SEC filings from Jan 2024 to Oct 2025, including 9 8-K, 5 10-Q, 1 8-K/A. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of IMTH filings?

Across 17 filings, the sentiment breakdown is: 17 neutral. The dominant sentiment is neutral.

Where can I find Antix Holdings, Inc. SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Antix Holdings, Inc. (IMTH) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Antix Holdings, Inc.?

Key financial highlights from Antix Holdings, Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for IMTH?

The investment thesis for IMTH includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Antix Holdings, Inc.?

Key executives identified across Antix Holdings, Inc.'s filings include Michael Friedman.

What are the main risk factors for Antix Holdings, Inc. stock?

Of IMTH's 16 assessed filings, 0 were flagged high-risk, 9 medium-risk, and 7 low-risk.

What are recent predictions and forward guidance from Antix Holdings, Inc.?

Forward guidance and predictions for Antix Holdings, Inc. are extracted from SEC filings as they are enriched.

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.